Document is current

Article History

Received: 22 November 2021

Accepted: 20 March 2022

First Online: 8 April 2022

Declarations

:

: Not applicable.

: Not applicable.

: Marnix Lam, MD, PhD: Is a consultant for Boston Scientific, Terumo and Quirem Medical. He receives research support from Boston Scientific, Terumo and Quirem Medical. The UMC Utrecht receives royalties from Quirem Medical.Etienne Garin, MD, PhD: Serves as a consultant for Boston Scientific.Marco Maccauro, MD: Nothing to disclose.S. Cheenu Kappadath, PhD: Is a consultant for Boston Scientific, Sirtex, and ABK Biomedical. He receives research support from Sirtex.Daniel Y. Sze, MD, PhD: Was a consultant for Argon, Artio Medical, Astra-Zeneca, Bayer, BlackSwan Vascular, Boston Scientific, Bristol Myers Squibb, Eisai, FluidX, W. L. Gore, Guerbet, Koli, Sirtex, Terumo, TriSalus, and Varian; received institutional research support from Boston Scientific, W. L. Gore, Merit Medical, and Sirtex; held equity in BlackSwan Vascular, Confluent Medical, Koli, Proteus Digital Health, Radiaction, and TriSalus; and serves on data safety monitoring boards for W. L. Gore and Replimune.Cuneyt Turkmen, MD: Nothing to disclose.Murat Cantasdemir, MD: Is a consultant for Boston Scientific.Paul Haste, MD: Is a consultant for Boston Scientific.Ken Herrmann, MD: Reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, outside the submitted work.Hamad Saleh Alsuhaibani, MD: Nothing to disclose and no conflict of interest.Matthew Dreher, PhD: Works for Boston Scientific.Kirk D. Fowers, PhD: Works for Boston Scientific.Riad Salem, MD: Is a consultant for Boston Scientific, Astrazeneca, Genentech, Sirtex, Cook, Eisai, Bard and QED Therapeutics.